Skeletal integrity and visceral transplantation

American Journal of Transplantation

Volumn 10, Issue 10, 2010, Pages 2331-2340

  Resnick, J ^a   Gupta, N ^a   Wagner, J ^a   Costa, G ^b   Cruz Jr , R J ^b   Martin, L ^b   Koritsky, D A ^b   Perera, S ^a,c   Matarese, L ^b   Eid, K ^b   Schuster, B ^b   Roberts, M ^a   Greenspan, S ^a   Abu Elmagd, K ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bone mineral density; immunosuppression; intestinal failure; multivisceral transplant; osteoporosis; parenteral nutrition (PN); small bowel transplant

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PARATHYROID HORMONE[1-34];

ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; BONE DENSITY; BONE MASS; CONTROLLED STUDY; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE GRAFT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; OSTEOLYSIS; OSTEOPOROSIS; PARENTERAL NUTRITION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SURVIVOR; VITAMIN D DEFICIENCY;

ADULT; ALENDRONATE; BIOLOGICAL MARKERS; BONE DENSITY; FEMALE; FRACTURES, BONE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INTESTINES; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOPOROSIS; PARENTERAL NUTRITION, HOME; PENNSYLVANIA; RETROSPECTIVE STUDIES; SURVIVORS; VITAMIN D DEFICIENCY;

EID: 77957203373     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03245.x     Document Type: Article

References (53)

1. Abu-Elmagd KM, Bond G, Reyes J, Fung J. Intestinal transplantation: A coming of age. Adv Surg 2002 36: 65 101.
2. Grant D, Abu-Elmagd K, Reyes J et al. 2003 Report of the intestine transplant registry: A new era has dawned. Ann Surg 2005 241: 607 613. (Pubitemid 40397308)
3. Abu-Elmagd KM, Costa G, Bond GJ et al. Five hundred intestinal and multivisceral transplantations at a single center. Ann Surg 2009 250: 567 581.
4. Cohen-Solal M, Baudoin C, Joly F et al. Osteoporosis in patients on long-term home parenteral nutrition: A longitudinal study. J Bone Miner Res 2003 18: 1989 1994. (Pubitemid 37377448)
5. Ferrone M, Geraci M. A review of the relationship between parenteral nutrition and metabolic bone disease. Nutr Clin Pract 2007 22: 329 339.
6. Matarese LE, Dvorchik I, Costa G et al. Pyridoxal-5'-phosphate deficiency after intestinal and multivisceral transplantation. Am J Clin Nutr 2009 89: 204 209.
7. Lewiecki EM, Gordon CM, Baim S et al. Special report on the 2007 adult and pediatric position development conferences of the international society for clinical densitometry. Osteoporos Int 2008 19: 1369 1378. (Pubitemid 351602184)
8. McMahon C, Abu-Elmagd K, Bontempo FA, Kant JA, Swerdlow SH. JAK2 V617F mutation in patients with catastrophic intra-abdominal thromboses. Am J Clin Pathol 2007 127: 736 743.
9. Abu-Elmagd K, Reyes J, Bond G et al. Clinical intestinal transplantation: A decade of a single center experience. Ann Surg 2004 234: 404 417.
10. Abu-Elmagd K. Indications and patient selection. In: Langnas A, Goulet O, Quigley E, Tappenden K, eds. Intestinal Failure: Diagnosis, Management and Transplantation. Oxford, UK: Blackwell Publishing, 2008: 245 253.
11. Giraldo M, Martin D, Colangelo J et al. Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc 2000 32: 1223 1224.
12. Varney LF, Parker RA, Vincelette A, Greenspan SL. Classification of osteoporosis and osteopenia in postmenopausal women is dependent on site-specific analysis. J Clin Densitom 1999 2: 275 283.
13. Kanis JA, Melton LJ, III., Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994 9: 1137 1141. (Pubitemid 24985932)
14. Kanis JA, for the WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. Osteoporos Int 1994 4: 368 381.
15. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic R et al. Peak bone mass. Osteoporos Int 2000 11: 985 1009. (Pubitemid 32144591)
16. Matkovic V, Jelic T, Wardlaw GM, IIich JZ. Timing of peak bone mass in caucasian females and its implication for the prevention of osteoporosis. J Clin Invest 1994 93: 799 808.
17. Henry YM, Fatayerji D, Eastell R. Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: Relative contributions of bone size and volumetric bone mineral density. Osteoporos Int 2009 15: 263 273. (Pubitemid 38543944)
18. Costa L, Badia X, Chow E, Lipton A, Wardley A. Impact of skeletal complications on patients' quality of life, mobility, and functional independence. Support Care Cancer 2008 16: 879 889.
19. Abu-Elmagd KM, Costa G, Bond GJ et al. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int 2009 22: 96 109
20. Peter R. Ebeling. Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab 2009 94: 1483 1490.
21. Schulte C, Beelen DW, Schaefer UW, Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: A prospective study. Osteoporos Int 2000 11: 344 353. (Pubitemid 30417188)
22. Ball AM, Gillen DL, Sherrard D et al. Risk of hip fracture among dialysis and renal transplant recipients. JAMA 2002 288: 3014 3018. (Pubitemid 35471163)
23. Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 2001 69: 321 326. (Pubitemid 34056794)
24. Shane E, Mancini D, Aaronson K et al. Bone mass, vitamin D deficiency and hyperparathyroidism in congestive heart failure. Am J Med 1997 103: 197 207. (Pubitemid 27413402)
25. Shane E, Silverberg SJ, Donovan D et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996 101: 262 269. (Pubitemid 26392439)
26. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998 395: 763 770. (Pubitemid 28485436)
27. Wood RJ, Bengoa JM, Sitrin MD, Rosenberg IH. Calciuretic effect of cyclic versus continuous total parenteral nutrition. Am J Clin Nutr 1985 41: 614 619. (Pubitemid 15149774)
28. Haderslev KV, Tjellesen L, Haderslev PH, Staun M. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. JPEN 2004 28: 289 294. (Pubitemid 39121448)
29. Puder M, Valim C, Meisel JA et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009 250: 395 402.
30. Nakchbandi IA, Van Der Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol 2009 6: 660 670.
31. Hay JE, Guichelaar MM. Evaluation and management of osteoporosis in liver disease. Clin Liver Dis 2005: 9: 747 766. (Pubitemid 41406398)
32. Leslie WD, Bernstein CN, Leboff MS. American Gastroenterological Association Clinical Practice Commitee. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003 125: 941 966.
33. Guañabens N, Parés A, Ros I et al. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 2005 42: 573 577. (Pubitemid 40342938)
34. Yakar S, Rosen CJ, Beamer WG et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 2009 110: 771 781.
35. Zarjou A, Jeney V, Arosio P et al. Ferritin-ferroxidase activity: A potent inhibitor of osteogenesis. J Bone Miner Res 2009 25: 164 172.
36. Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002 35: 126 131. (Pubitemid 34032552)
37. Shane E, Papadopoulos A, Staron RB et al. Bone loss and fracture after lung transplantation. Transplantation 1999 68: 220 227. (Pubitemid 29360280)
38. Chae YS, Kim JG, Moon JH et al. Pilot study on the use of zoledronic acid to prevent bone loss in Allo-SCT recipients. Bone Marrow Transplant 2009 44: 35 41.
39. Crawford BA, Kam C, Pavlovic J et al. Zoledronic acid prevents bone loss after liver transplantation: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2006 144: 239 248. (Pubitemid 46768206)
40. Herman S, Krönke G, Schett G. Molecular mechanisms of inflammatory bone damage: Emerging targets for therapy. Trends Mol Med 2008 14: 245 253.
41. Tilg H, Moschen AR, Kaser A, Pines A, Dotan I. Gut inflammation and osteoporosis: Basic and clinical concepts. Gut 2008 57: 684 694. (Pubitemid 351579985)
42. Abu-Elmagd K, Todo S, Tzakis A et al. Intestinal transplantation and bacterial overgrowth in humans. Transplant Proc 1994 26: 1684 1685. (Pubitemid 24211728)
43. Abu-Elmagd K, Reyes J, Fung JJ. Transplantation of the human intestine: The forbidden organ. Curr Opin Organ Transplant 1998 3: 286 292.
44. Ebling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. JBMR 1999 14: 342 350. (Pubitemid 29106711)
45. Grigg AP, Shuttleworth P, Reynolds J et al. Pamidronate reduces bone loss after allogeneic stem cell transplantation. J Clin Endorinol Metab 2006 91: 3835 3843. (Pubitemid 44536852)
46. Ippoliti G, Pellegrini C, Campana C et al. Clodronate treatment of established bone loss in cardiac recipients: A randomized study. Transplantation 2003 75: 330 334. (Pubitemid 36222957)
47. Toro J, Gentil MA, García R et al. Alendronate in kidney transplant patients: A single-center experience. Transplant Proc 2005 37: 1471 1472. (Pubitemid 40712087)
48. Kasturi KS, Chennareddygari S, Mummadi RR. Effect of bisphosphonates on bone mineral density in liver transplant patients: A meta-analysis and systematic review of randomized controlled trials. Transpl Int 2009 23: 200 207.
49. Silverman SL. New therapies for osteoporosis: Zoledronic acid, bazedoxifene, and denosumab. Curr Osteoporos Rep 2009 7: 91 95.
50. Tauchmanovà L, De Simone G, Musella T et al. Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation. Bone Marrow Transplant 2006 37: 81 88. (Pubitemid 43135319)
51. Coco M, Glicklich D, Faugere MC et al. Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 2003 14: 2669 2676. (Pubitemid 37169355)
52. Bodingbauer M, Wekerle T, Pakrah B et al. Prophylactic bisphosphonate treatment prevents bone fractures after liver transplantation. Am J Transplant 2007 7: 1763 1769. (Pubitemid 46905434)
53. Cummings SR, San Martin J, McClung MR et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. Engl J Med 2009 361: 756 765.